Collectively, the studies on gastric cancer consistently implicate miR-21 in promoting invasion, metastasis, chemoresistance, and metabolic reprogramming, frequently converging on the PTEN/PI3K/Akt pathway, while also highlighting its connection to inflammatory signaling and its potential as a clinical biomarker. This evidence concerns the gene PTEN and gastric cancer.